- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Study Finds Most Expensive of Eye Treatment Options Is Most Effective
Study finds that Regeneron Pharmaceuticals' more expensive Eylea help patients with severe eye disease caused by diabetes more than the less-expensive options from Roche Holding.
Regeneron Pharmaceuticals Inc.’s injection Eylea helped patients with severe eye disease caused by diabetes more than 2 Roche Holding AG medicines in the first head-to-head study of the drugs.
The finding may lead to doctors shifting more patients with diabetic macular edema to more-expensive Eylea, a boost for Regeneron since the drug generates about two-thirds of the company’s sales. Eylea performed significantly better than the Roche drugs in people with moderate to severe vision loss, making it the preferred choice, said Daniel Martin, chairman of the Cleveland Clinic’s Cole Eye Institute.
Read more at Bloomberg: http://bloom.bg/1DFfWf8
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen
